课题基金 / 基金详情

MOLECULAR PHARMACOLOGY OF TUMOR AND VIRUS INHIBITORS

MOLECULAR PHARMACOLOGY OF TUMOR AND VIRUS INHIBITORS
肿瘤和病毒抑制剂的分子药理学
批准号:
6341823
负责人:
Arthur Patrick Grollman
金额:
$43.91万
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-01-01 至 2002-02-28

项目摘要

项目成果

Arthur Patrick Grollman的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research focusses on the biological consequences of DNA damage with the overall goal of elucidating primary events in carcinogenesis. A principal theme is to establish relationships between the structure of damaged DNA and the functions of enzymes involved in DNA replication and repair. Novel experimental systems have been developed for this purpose. Site specific mutagenesis involves a strategy in which a shuttle plasmid vector, containing a single defined lesion, is allowed to replicate in mammalian cells or bacteria. The position of mutations induced is established by DNA sequence analysis. Primer-extension reactions, catalyzed by DNA polymerase, coupled with steady-state kinetic analysis, are used to explore translesional synthesis and mutagenic events in vitro. Our specific aims are (a) to establish models for frameshift mutagenesis in terms of misaligned DNA templates and kinetics governing translesional synthesis; (b) to elucidate the molecular basis underlying sequence context effects on base substitutions and deletions; (c) to understand the role of SOS functions in translesional synthesis; (d) to discover pathways by which mutations are generated during repair of bistrand abasic sites in DNA; (e) to demonstrates differences between DNA polymerases in their abilities to generate mutations arising from DNA damage; (f) to develop in vitro assays that predict mutagenic specificity for defined DNA lesions in vivo; (g) to explore mechanisms by which DNA damage enhances the frequency of homologous recombination in mammalian cells and bacteria; and (h) to establish the solution structure of misaligned intermediates formed during deletion mutagenesis. Additional studies are designed (a) to determined the substrate specificity of Fpg protein; (b) to establish the role of the N-terminus in the catalytic function of this enzyme; (c) to reveal the structural basis for binding of the zinc finger domain oxidatively-damaged DNA; (d) to elucidate a catalytic mechanism for DNA glycosylate activity; (e) to detect functional groups on Fpg protein and its substrates that facilitate "recognition" of oxidative damage; (f) to establish the structure of complexes formed between Fpg protein or adenine DNA glycosylate and analogs of their DNA substrates; and (g) to study substrate binding and mechanism of action of selected AP endonucleases, and (h) to quantify the contribution of Fpg protein to DNA repair in cells.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells.
哺乳动物细胞中人类 Ha-ras 序列中独特的 8-氧代鸟嘌呤的致突变性。
DOI: 10.1093/carcin/16.11.2779
发表时间: 1995
期刊: Carcinogenesis
影响因子: 4.7
作者: [LePage,F, Margot,A, Grollman,AP, Sarasin,A, Gentil,A]
通讯作者: Gentil,A
Inhibition of cellular thymidylate synthesis by cytotoxic propenal derivatives of pyrimidine bases and deoxynucleosides.
嘧啶碱基和脱氧核苷的细胞毒性丙烯醛衍生物抑制细胞胸苷酸合成。
DOI: 10.1016/0006-2952(91)90732-k
发表时间: 1991
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Kalman,TI, Marinelli,ER, Xu,B, Reddy,AR, Johnson,F, Grollman,AP]
通讯作者: Grollman,AP
Miscoding properties of model estrogen-DNA adducts in reactions catalyzed by mammalian and Escherichia coli DNA polymerases.
哺乳动物和大肠杆菌 DNA 聚合酶催化反应中模型雌激素-DNA 加合物的错误编码特性。
DOI: 10.1021/bi962275q
发表时间: 1997
期刊: Biochemistry.
影响因子: --
作者: [Shibutani,S, Itoh,S, Yoshizawa,I]
通讯作者: Yoshizawa,I
Mechanism of mutation on DNA templates containing synthetic abasic sites: study with a double strand vector.
含有合成脱碱基位点的 DNA 模板的突变机制:使用双链载体进行研究。
DOI: 10.1093/nar/22.10.1897
发表时间: 1994
期刊: Nucleic acids research
影响因子: 14.9
作者: [Takeshita,M, Eisenberg,W]
通讯作者: Eisenberg,W
25
    PROJECT 3- TOXICOGENOMICS ARISTOLOCHIC ACID NEPHROPATHY
    ADMINISTRATIVE CORE
    PROJECT 3- TOXICOGENOMICS ARISTOLOCHIC ACID NEPHROPATHY
    Etiology of Balkan endemic nephropathy